First Mercantile Trust’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

First Mercantile Trust’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-385	Closed	-$37K	–	928
2019 Q3	$37K	Hold	385	–	–	﹤0.01%	848
2019 Q2	$39K	Sell	385 -140	-27%	-$15.1K	﹤0.01%	779
2019 Q1	$60K	Sell	525 -605	-54%	-$44.5K	0.01%	756
2018 Q4	$44K	Buy	1,130 +190	+20%	+$8.24K	0.01%	794
2018 Q3	$51K	Buy	940 +5	+0.5%	+$342	0.01%	794
2018 Q2	$77K	Sell	935 -130	-12%	-$10K	0.02%	765
2018 Q1	$71K	Buy	1,065 +790	+287%	+$45.6K	0.01%	720
2017 Q4	$14K	Buy	+275	New	+$19.8K	﹤0.01%	803

First Mercantile Trust's ONCE Position: Q4 2019 in Review

First Mercantile Trust sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 385 shares — an estimated $37K sold.

First Mercantile Trust first reported a position in ONCE in Q4 2017 and held it in 8 quarters. The position peaked at $77K in Q2 2018. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

First Mercantile Trust reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
First Mercantile Trust sold 385 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $37K.
First Mercantile Trust first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
First Mercantile Trust's Spark Therapeutics, Inc. Common Stock position peaked at $77K in Q2 2018.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on First Mercantile Trust's 13F filing for Q4 2019, filed 31 Jan 2020.